Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a single pen. The pen could serve as a more convenient option for some ...
Many people living with rheumatoid arthritis (RA) rely on long-term medications to manage joint pain, stiffness, and inflammation. A number of these treatments are given as subcutaneous injections, ...
As part of the back-to-school rush, GoodRx, a platform for medication savings, reports the demand for epinephrine (EpiPen, EpiPen Jr, Adrenaclick, Auvi-Q) auto-injectors tends to spike in the summer ...
Health insurance companies love to save money. Who doesn’t? But the calculations for what’s cheapest don’t always look the way you’d expect. Insurers will sometimes choose to cover a significantly ...
DETROIT & BOSTON--(BUSINESS WIRE)--Sempresto, Inc., a medical device company pioneering smartphone integrated rescue drug delivery, today announced the acquisition of Alerje’s mobile device integrated ...
Injection molder Engineered Plastic Components (EPC) plans to invest $13.5 million in an expansion in northwest Ohio to support its partnership with Whirlpool and increase capacity for the automotive ...
Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? An at-home corticosteroid injection that can be used to treat angry, inflammed ...
The Alzheimer's treatment Leqembi is prepared at Abington Neurological Associates in Abington, PA., on November 7, 2023. The medicine is now available in a self-injecting pen, Leqembi Iqlik. Credit - ...
If you or someone you love has an allergy that results in anaphylaxis, you know how important it is to administer epinephrine at the first sign of a reaction. Epinephrine is the frontline treatment ...
Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESAIY) announced the rolling submission of a marketing application to receive an FDA label expansion for a subcutaneous autoinjector that delivers their Alzheimer ...
(RTTNews) - Eisai Co., Ltd. (ESALY.PK, ESALF.PK) and Biogen Inc. (BIIB) announced that Eisai has initiated the rolling submission of the Supplemental Biologics License Application (sBLA) to the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results